Texas Capital Bancshares Inc/Tx (TCBIO) EPS (Basic) (2010 - 2026)

Texas Capital Bancshares (TCBIO) has reported EPS (Basic) for 17 consecutive years, with $1.85 the latest figure, recorded in Q2 2026.

• Quarterly EPS (Basic) rose 15.99% year-over-year to $1.85 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $7.97 (up 212.27% YoY) and the FY2025 annual result came in at $6.86, up 429.88% from the prior year.
• EPS (Basic) climbed to $1.85 in Q2 2026 per TCBIO's latest filing, from $1.58 in the prior quarter.
• Over the last five years, EPS (Basic) for TCBIO reached as high as $4.22 in Q4 2022 and fell as low as -$1.42 in Q3 2024.
• A 5-year average of $1.19 and a median of $1.06 in 2025 frame the typical range for EPS (Basic).
• The largest YoY upside for EPS (Basic) was 334.74% in 2024 against a maximum downside of 218.88% in 2024.
• Year by year, EPS (Basic) stood at $4.22 in 2022, then slumped by 92.19% to $0.33 in 2023, then surged by 334.74% to $1.43 in 2024, then surged by 47.33% to $2.11 in 2025, then fell by 12.39% to $1.85 in 2026.
• According to Business Quant data, EPS (Basic) over the past three periods registered $1.85, $1.58, and $2.11 for Q2 2026, Q1 2026, and Q4 2025 respectively.